TUG VALLEY ARH
1. Target Overview & Investment Thesis
TUG VALLEY ARH is a 88-bed under-performing / distressed in PIKE, KY with $46.3M in net patient revenue and a -29.2% operating margin. The hospital serves a payer mix of 30.2% Medicare, 0.1% Medicaid, and 69.6% commercial.
Thesis: Turnaround. Our ML models identify $3.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -29.2% to -21.8% (+736bps).
| Net Revenue HCRIS | $46.3M |
| Current EBITDA COMPUTED | $-13.5M |
| Operating Margin COMPUTED | -29.2% |
| Occupancy HCRIS | 19.9% |
| Revenue / Bed COMPUTED | $527K |
| Net-to-Gross HCRIS | 17.5% |
| Distress Probability ML | 53.8% |
2. Market Context & Competitive Position
KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -29.2% places it below the state median. Among 47 size-comparable peers (44-176 beds), the median margin is -3.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (44-176), prioritizing same-state peers. 47 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| TUG VALLEY ARH (Target) | KY | 88 | $46.3M | -29.2% |
| BAPTIST HEALTH MADISONVILLE | KY | 154 | $220.0M | -5.7% |
| ST. ELIZABETH FLORENCE | KY | 134 | $212.6M | 8.8% |
| SAINT JOSEPH EAST | KY | 138 | $209.5M | 2.6% |
| EPHRAIM MCDOWELL REG MED CTR | KY | 157 | $207.7M | -13.8% |
| ST. CLAIRE MEDICAL CENTER | KY | 100 | $204.5M | -8.5% |
| HAZARD ARH | KY | 109 | $200.8M | -32.3% |
| T.J. SAMSON COMMUNITY HOSPITAL | KY | 112 | $189.4M | -10.5% |
| SAINT JOSEPH LONDON | KY | 118 | $173.7M | -8.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $973K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $927K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $917K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $564K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $30K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-13.5M |
| + RCM Uplift | +$3.4M |
| Pro Forma EBITDA | $-10.1M |
| Current Margin | -29.2% |
| Pro Forma Margin | -21.8% |
| WC Released (1x) | $1.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-20.8M | $-55.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-20.8M | $-67.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-18.7M | $-62.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-18.7M | $-74.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-22.9M | $-65.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-22.9M | $-79.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 19.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 47 hospitals with 44-176 beds
- Same-state prioritization (n=48)
- Comp margins: P25=-11.0% / P50=-3.4% / P75=10.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.